About this trial
This study aims to evaluate the validity and reliability of neuroscience-based visual laser feedback map tests in individuals with Motoric Cognitive Risk Syndrome (MCRS). The developed assessment protocol integrates visuospatial processing, reaction time, and upper extremity motor control within a single task. Construct validity will be examined through correlations with reaction time and proprioception measurements, and test-retest reliability will be assessed to determine measurement consistency.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Community-dwelling older adults aged 65 years and above diagnosed with Motoric Cognitive Risk Syndrome will be recruited from the Tazelenme University Coordination Unit in Balıkesir, Turkey. The study population represents individuals at risk of cognitive decline but without diagnosed dementia, enabling the evaluation of early-stage cognitive-motor interaction.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Visual-laser feedback map test performance
Performance parameters including completion time (seconds), reaction time (milliseconds), movement accuracy, and total performance score obtained from the figure-of-eight tracing and directional target tracking tasks.
Secondary outcomes
Reaction time
Reaction time will be assessed using the Light Trainer system. The response time to visual stimuli will be recorded in milliseconds.
Shoulder proprioception
Shoulder joint position sense will be assessed using the joint repositioning test. Absolute error will be recorded in degrees.
Test-retest reliability
Test-retest reliability of the visual-laser feedback map tests will be evaluated using the Intraclass Correlation Coefficient (ICC).
Measurement error
Measurement error will be calculated using the Standard Error of Measurement (SEM) and Minimal Detectable Change (MDC).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.